Loading clinical trials...
Loading clinical trials...
The aim of the present study is to examine the inflammatory response in the pulmonary compartment and blood of critically ill patients admitted to the ICU with COVID-19.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hvidovre University Hospital
NCT06501118 · Respiratory Failure, Acute Hypoxemic Respiratory Failure, and more
NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more
NCT05101213 · Adenovirus Infection, BK Virus Infection, and more
NCT04565665 · COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, and more
NCT06213168 · De Novo Hypoxemic Acute Respiratory Failure (hARF)
Dept. of Intensive Care 542, University Hospital Hvidovre
Hvidovre, Copenhagen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions